Back to CVE records
High 7.0Published Sep 29, 2026

CVE-2026-19547Local Privilege Escalation in Ghostscript for Windows

Updated under an hour ago ()

Does this affect you?

It affects Artifex Software Inc. Ghostscript. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.16%, higher than 5% of scored CVEs.

Ghostscript for Windows is vulnerable to local privilege escalation through PostScript resource file hijacking. Due to the application searching for PostScript resource files in predictable paths under C:\\gs\\ that do not exist by default on Windows installations, combined with Windows default ACLs allowing any authenticated user to create directories at the root of C:\\, an attacker who is an authenticated local user can create the expected directory structure and plant a malicious PostScript file. When any user or service subsequently runs Ghostscript, the planted file is automatically loaded and executed with the full privileges of the Ghostscript process. This results in full compromise of Ghostscript process context, as well as running arbitrary code on the machine with Ghostscript process privileges. This issue was fixed in version 10.08.0.

CVSS
7.0 HIGH (v4.0, CNA)CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:L/SI:L/SA:N
Weakness (CWE)
CWE-426
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.16% (percentile 5)
Assigned by
CERT-PL
NVD analysis
Awaiting Analysis
Record last updated
Sep 29, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Artifex Software Inc. Ghostscript
artifex_software:ghostscript (from the name)
before 10.08.0
CNA record

References

  • third-party-advisory
  • product
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.